Skip to main content
. 2022 Jun 30;9(11):100110. doi: 10.1016/j.apjon.2022.100110

Table 2.

Basic characteristics of included studies.

Study Country Study design Cases ERAS/control %
Male
Intervention measures Outcomes
Alessan 2017 United Kingdom RCS 235/365 42.1/40 A, B, C, E, H, J, I, M complication
Amin 2015 Canada RCS 107/127 61/45 A, F, H, I, J, K Complication, LOS, chest tube indwelling time
Cai 2018 China PCS 62/59 66.1/66.1 A, C, E, F, H, I, J, K VAS, LOS, first ambulation, complication
Che 2018 China RCT 75/75 66.7/64 A, E, F, H, I VAS, chest tube indwelling time, LOS, first ambulation, complication
Fan 2019 China RCT 100/80 63/63.8 A, C, E, F, H, I, J, L LOS, chest tube indwelling time, first ambulation, complication
Forster 2021 Switzerland RCS 140/167 47.1/58.7 A, E, F, H, I, J Complication, LOS, chest tube indwelling time
Greg 2019 USA PCS 126/169 31/43.8 C, E, F, H, I LOS
Huang 2018 China RCS 38/45 42.1/55.6 A, B, C, F, H, I, J Complication, VAS, chest tube indwelling time, LOS
Li 2017 China RCT 80/80 66.3/61.3 A, F, H, J, K VAS, LOS, complication, chest tube indwelling time, first ambulation
Li 2018 China RCT 50/50 60/62 A, B, F, H, I, J, K VAS, LOS, complication, chest tube indwelling time
Li 2020 China RCT 40/40 67.5/62.5 A, C, E, F, H, I, J, K QoL, complication
Michele 2012 Italy RCS 232/232 NR A, B, C, D, E, F, H, I, J, K, M Complication, LOS
Robert 2018 USA RCS 342/1615 47.4/50 A, B, E, F, H, I, J, K, L Complication, LOS, chest tube indwelling time
Satoshi 2019 Japan RCS 130/405 66.2/57 A, B, C, D, E, F, G, H, I, J, K, L, M Complication
Tahiri 2020 Canada RCS 98/98 36.7/29.6 A, C, E, F, H, I, J, K Complication, LOS, chest tube indwelling time, first ambulation
Wang 2015 China RCT 54/54 68.5/64.8 A, B, C, E, F, H, I, J, K, L VAS, chest tube indwelling time, first ambulation, LOS, complication
Wang 2019 China RCT 45/45 68.9/64.4 A, E, H, I, J, K, L VAS, LOS, first ambulation, complication, chest tube indwelling time
Wang 2021 China RCS 691/1058 50.8/49.8 A, C, D, E, F, H, J, K Complication, LOS, chest tube indwelling time
Xu 2020 China PCS 60/60 46.7/55 A, B, C, E, F, H, I, J, K VAS, LOS, complication
Zhang 2017 China RCT 50/50 52/50 A, B, C, E, F, H, I, J, K VAS, chest tube indwelling time, QoL, complication, LOS
Zhang 2019 China RCT 106/106 65.1/51.9 A, B, D, E, F, H, I, J, K, L VAS, chest tube indwelling time, LOS, first ambulation, complication
Zhao 2010 China RCT 38/36 63.2/69.4 C, D, E, F, H, I VAS, LOS, complication
Zheng 2019 China RCT 43/43 67.4/72.1 A, E, F, G, H, I, J, K VAS, LOS, chest tube indwelling time, QoL, complication

ERAS, enhanced recovery after surgery; RCT, randomized controlled trial; PCS, prospective cohort study; RCS, retrospective cohort study; VAS, visual analog scale; QoL, quality of life; LOS, length of stay.

Intervention measures. Preoperative (A) Patient education, the importance of smoking and alcohol reduction, and nutritional supplements (B) Respiratory function exercise and incentive spirometer instruction (C) Shortened fasting and water period (D) Psychological care, good communication through understanding needs. Intraoperative (E) Intraoperative warming, such as controlling the temperature of the operating room, applying warm water bags and other devices (F) Optimizing the anesthesia method, selecting the appropriate anesthetic drugs (G) Avoidance of fluid overload. Postoperative (H) Multimodal analgesia (I) Restriction of use/early removal of surgical drains (J) Early mobilization, basic activities in bed after awakening, and getting out of bed 1 day after surgery (K) Early feeding (L) Respiratory function exercise (M) Fluid therapy targeting euvolemia.